AI Predicts Chronic GVHD Risk After Stem Cell Transplant
Key Takeaways A new AI-driven tool, BIOPREVENT, predicts chronic GVHD and transplant-related mortality before symptoms appear Combines immune biomarkers, clinical
Read MoreKey Takeaways A new AI-driven tool, BIOPREVENT, predicts chronic GVHD and transplant-related mortality before symptoms appear Combines immune biomarkers, clinical
Read MoreEnhancing Patient Care Through Biomarkers More than 1,500 individuals in Norway have undergone liver transplantation, a life-saving procedure for patients
Read More